在创伤性脑损伤与失血性休克猪模型中延长丙戊酸治疗时间窗
该研究在Yorkshire猪(40-45 kg,n=10)中造成控制性皮层撞击TBI并放血40%血容量,休克2小时后随机分为生理盐水复苏(对照)或生理盐水-丙戊酸(150 mg/kg×2剂),首剂于TBI后3小时开始、第二剂于首剂后8小时给予。丙戊酸组伤后第2天(16.3±2.0 vs. 7.3±2.8)和第3天(10.9±3.6 vs. 2.8±1.1)神经功能损害显著更轻,且恢复至基线水平快54%;伤后第3天MRI脑病灶大小无差异;药代动力学数据证实循环中丙戊酸达到神经保护水平。作者认为这是首次证明TBI后3小时给予VPA仍可神经保护,扩展的时间窗对临床试验设计有重要意义。
要点
- TBI合并40%失血性休克猪模型中,伤后3小时启动丙戊酸(150 mg/kg×2剂,首剂后8小时第二剂)仍显示神经保护作用。
- 丙戊酸组伤后第2天神经功能损害评分16.3±2.0 vs. 对照组7.3±2.8,第3天10.9±3.6 vs. 2.8±1.1,均显著更轻。
- 丙戊酸组神经功能恢复至基线水平较对照组快54%。
- 伤后第3天MRI脑病灶大小两组无差异;药代动力学证实循环中丙戊酸达神经保护水平。
- 作者认为该扩展时间窗对临床试验设计有重要意义,这是首个证明TBI后3小时给VPA仍神经保护的研究。
适用人群与场景
- Yorkshire猪(40-45 kg,n=10),遭受控制性皮层撞击TBI及40%血容量失血性休克,休克2小时后随机分组。
处置流程与药物剂量
- 丙戊酸组:生理盐水-丙戊酸150 mg/kg×2剂,首剂于TBI后3小时开始,第二剂于首剂后8小时给予。
- 对照组:生理盐水复苏。
研究设计与关键结果
- 研究类型:动物实验(猪TBI合并失血性休克模型),样本量n=10,随机分为生理盐水复苏(对照)或生理盐水-丙戊酸(150 mg/kg×2剂)。
- 主要终点:神经功能损害评分(范围0-36)伤后第2天丙戊酸组16.3±2.0 vs. 对照组7.3±2.8,第3天10.9±3.6 vs. 2.8±1.1,丙戊酸组显著更轻;丙戊酸组恢复至基线水平快54%。
- 次要终点:伤后第3天MRI脑病灶大小两组无差异;药代动力学数据证实循环中丙戊酸达神经保护水平。
- 两组血流动力学和休克实验室参数相似。
证据类型、等级与局限
- 证据类型:动物实验(猪模型),原文未报告证据等级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为这是首次证明TBI后3小时给予VPA仍可神经保护,扩展的治疗时间窗对临床试验设计有重要意义。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: It has previously been shown that administration of valproic acid (VPA) can improve outcomes if given within an hour following traumatic brain injury (TBI). This short therapeutic window (TW) limits its use in real-life situations. Based upon its pharmacokinetic data, we hypothesized that TW can be extended to 3 hours if a second dose of VPA is given 8 hours after the initial dose.
METHOD: Yorkshire swine (40-45 kg; n = 10) were subjected to TBI (controlled cortical impact) and 40% blood volume hemorrhage. After 2 hours of shock, they were randomized to either (1) normal saline resuscitation (control) or (2) normal saline-VPA (150 mg/kg × two doses). First dose of VPA was started 3 hours after the TBI, with a second dose 8 hours after the first dose. Neurologic severity scores (range, 0-36) were assessed daily for 14 days, and brain lesion size was measured via magnetic resonance imaging on postinjury day 3.
RESULTS: Hemodynamic and laboratory parameters of shock were similar in both groups. Valproic acid-treated animals had significantly less neurologic impairment on days 2 (16.3 ± 2.0 vs. 7.3 ± 2.8) and 3 (10.9 ± 3.6 vs. 2.8 ± 1.1) postinjury and returned to baseline levels 54% faster. Magnetic resonance imaging showed no differences in brain lesion size on day 3. Pharmacokinetic data confirmed neuroprotective levels of VPA in the circulation.
CONCLUSION: This is the first study to demonstrate that VPA can be neuroprotective even when given 3 hours after TBI. This expanded TW has significant implications for the design of the clinical trial.
参考来源
- Jin G, Ho JW, Keeney-Bonthrone TP, et al. Prolonging the therapeutic window for valproic acid treatment in a swine model of traumatic brain injury and hemorrhagic shock. J Trauma Acute Care Surg. 2023. PMID: 37314445. doi:10.1097/TA.0000000000004022
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。